비교리스트

 카트 문의
시장보고서
상품코드
1529748

세계의 간질 모니터링 기기 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Epilepsy Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Wearable Devices, Conventional Devices), By End-use (Neurology Centers, Diagnostic Centers), By Region, And Segment Forecasts, 2024 - 2030
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 114 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

간질 모니터링 기기 시장 동향

전 세계 간질 모니터링 기기 시장 규모는 2023년 5억 5,900만 달러로 추정되며, 2024-2030년간 연평균 6.6% 성장할 것으로 예상됩니다. 이 시장은 간질 유병률 증가, 기술 발전, 외래 환자 모니터링에 대한 수요 증가, 웨어러블 기기 사용 증가, 정부 이니셔티브 증가 등 여러 요인에 의해 주도되고 있습니다.

또한, 진단 및 치료 개선에 대한 수요 증가, 시장 경쟁 심화, 원격 의료의 중요성 증가도 시장 성장을 가속하는 주요 요인 중 하나입니다. 간질의 유병률은 전 세계적으로 증가하고 있으며, 전 세계적으로 상당수의 환자가 간질을 앓고 있습니다.

세계보건기구(WHO)에 따르면, 간질은 전 세계적으로 약 5,000만 명이 앓고 있는 신경질환으로 전 세계적으로 가장 흔한 만성질환 중 하나입니다. 보고서에 따르면, 간질 환자의 약 80%가 중저소득 국가(LMIC)에 거주하고 있으며, 이들은 양질의 의료 서비스에 대한 접근이 제한되어 있는 경우가 많습니다. 간질은 반복적인 발작이 특징이며, 환자의 삶의 질에 큰 영향을 미칩니다. 간질을 효과적으로 진단하고 치료하기 위해서는 발작을 실시간으로 감지하고 추적할 수 있는 첨단 모니터링 기기가 필요합니다.

미국에서만 300만 명 이상의 간질 환자가 있는 것으로 추정됩니다. 또한 미국 질병예방통제센터(CDC)에 따르면, 2021년에는 18세 이상 미국 성인 중 약 290만 명이 활동성 간질을 앓고 있는 것으로 보고되고 있습니다.

웨어러블 기술과 데이터 분석의 발전은 간질 모니터링 기기 분야에 혁명을 일으켰습니다. 발작 감지 알고리즘이 탑재된 스마트워치와 피트니스 트래커는 심박수, 운동, 피부 전기 활동 등 환자의 생리적 데이터를 지속적으로 모니터링할 수 있게 되었습니다. 이를 통해 잠재적인 발작 에피소드를 실시간으로 감지할 수 있어 환자와 의료진에게 적시에 정확한 정보를 제공하여 치료 및 관리에 대한 정보에 입각한 의사결정을 내릴 수 있습니다. 예를 들어, 2024년 2월, 신경질환의 지속적이고 비침습적이며 눈에 띄지 않는 모니터링의 선구자인 엠파티카(Empatica Inc.)는 에피모니터(EpiMonitor)를 출시할 예정이라고 발표했습니다. 이 웨어러블 간질 모니터링 솔루션의 최신 혁신은 6세 이상의 성인과 소아를 대상으로 설계되었으며, 발작의 감지 및 관리에 탁월한 편의성과 정확성을 제공하는 최첨단 기술을 갖추고 있습니다.

또한, 간질 연구에 대한 자금 지원 및 투자 등 정부의 적극적인 노력도 예측 기간 동안 시장 성장을 가속할 것으로 예상됩니다. 예를 들어, 영국 간질연구소(Epilepsy Research Institute UK)는 영국 정부가 Medical Research Charities Early Career Researchers Support Fund를 통해 영국 간질연구소(Epilepsy Research UK)에 189만 달러 이상을 투자했다고 발표했습니다. 투자했다고 발표했습니다. 이 자선단체는 2022-23년에 135만 달러, 2021-22년에 562,010.5달러를 받았습니다. 또한 2024년 3월 영국 간질 협회는 암, 치매, 간질 연구에 4,866만 달러를 투자할 것이라고 발표했습니다.

간질 모니터링 기기 세계 시장 세분화 보고서

이 보고서는 2018-2030년간 세계, 지역 및 국가별 수익 성장을 예측하고 각 하위 부문의 최신 산업 동향 분석을 제공합니다. 이 조사에서 Grand View Research, Inc.는 간질 모니터링 기기 세계 시장 보고서를 제품, 최종 용도 및 지역에 따라 세분화했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 간질 모니터링 기기 시장 변수, 동향, 범위

  • 시장 계통 전망
    • 상위 시장 전망
    • 관련/보조적인 시장 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
  • 간질 모니터링 기기 시장 분석 툴
    • 업계 분석 - Porter의 Five Forces 분석
    • PESTEL 분석

제4장 간질 모니터링 기기 시장 : 제품, 추정·동향 분석

  • 제품 시장 점유율, 2023년과 2030년
  • 부문 대시보드
  • 제품별 세계의 간질 모니터링 기기 시장 전망
  • 시장 규모/예측 및 동향 분석(2018-2030년)

제5장 간질 모니터링 기기 시장 : 최종 용도, 추정·동향 분석

  • 최종 용도별 시장 점유율, 2023년과 2030년
  • 부문 대시보드
  • 최종 용도별 세계의 간질 모니터링 기기 시장 전망
  • 시장 규모/예측 및 동향 분석(2018-2030년)

제6장 간질 모니터링 기기 시장 : 지역 추정·동향 분석

  • 지역별 시장 점유율 분석, 2023년과 2030년
  • 지역 시장 대시보드
  • 세계 지역 시장 현황
  • 시장 규모, 예측 동향 분석, 2018-2030년 :
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제7장 경쟁 구도

  • 주요 시장 진출기업의 최근 동향과 영향 분석
  • 기업/경쟁 분류
  • 벤더 구도
    • 주요 기업의 시장 점유율 분석, 2023년
    • NIHON KOHDEN CORPORATION
    • Medtronic
    • GE Healthcare
    • Koninklijke Philips NV
    • Compumedics Limited
    • Natsu Medical
    • Cadwell Industries, Inc.
    • BrainScope Company, Inc.
    • Seer Medical
    • Stratus
LSH 24.08.19

Epilepsy Monitoring Devices Market Trends

The global epilepsy monitoring devices market size was estimated at USD 559.0 million in 2023 and is projected to grow at a CAGR of 6.6% from 2024 to 2030. The market is driven by several factors, such as the increasing prevalence of epilepsy, advances in technology, growing demand for ambulatory monitoring, rising use of wearable devices, and growing government initiatives.

Further, the increasing need for improved diagnosis and treatment, growing competition, and growing importance of telemedicine are also some of the primary factors fueling the market growth. The prevalence of epilepsy is increasing globally, with a significant number of people affected worldwide.

Epilepsy is a neurological disorder that affects an estimated 50 million people worldwide, making it one of the most common chronic conditions globally, according to the World Health Organization (WHO). According to the same report, around 80% of people with epilepsy live in low- and middle-income countries (LMIC), where access to quality healthcare is often limited. The condition is characterized by recurring seizures, which can have a significant impact on a person's quality of life. Effective diagnosis and treatment of epilepsy require advanced monitoring devices that can detect and track seizures in real-time.

In the U.S. alone, over 3 million individuals are estimated to be living with epilepsy. Further, in 2021, about 2.9 million U.S. adults 18 and older reported having active epilepsy, as per the U.S. Centers for Disease Control and Prevention.

The advancement of wearable technology and data analytics has revolutionized the field of epilepsy monitoring devices. The introduction of smartwatches and fitness trackers equipped with seizure detection algorithms has enabled the continuous monitoring of a patient's physiological data, including heart rate, movement, and electrodermal activity. This allows for detecting potential seizure episodes in real-time, providing patients and healthcare providers with timely and accurate information to make informed decisions about treatment and management. For instance, in February 2024, Empatica Inc., a pioneering company in continuous, non-invasive, and discreet monitoring for neurological conditions, announced the launch of EpiMonitor. This latest innovation in wearable epilepsy monitoring solutions is designed for adults and children aged 6 and above, offering cutting-edge technology that provides unparalleled convenience and accuracy in detecting and managing seizures.

Furthermore, growing government initiatives such as funding and investments for epilepsy research are expected to fuel the market's growth over the forecast period. For instance, Epilepsy Research Institute UK announced that the UK government has invested over USD 1.89 million in grant funding into Epilepsy Research UK through its Medical Research Charities Early Career Researchers Support Fund. The charity received USD 1.35 million in 2022-23 and USD 562,010.5 in 2021-22. Further, in March 2024, the British Epilepsy Association announced a USD 48.66 million investment into research for cancer, dementia, and epilepsy.

Global Epilepsy Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global epilepsy monitoring devices market report based on product, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Wearable Devices
  • Conventional Devices
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Neurology Centers
  • Diagnostic Centers
  • Regional Outlook (Revenue in USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

  • Latin America

Brazil

Argentina

  • Middle East and Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Epilepsy Monitoring Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising incidents of venom-bites
      • 3.2.1.2. Increasing R&D initiatives
      • 3.2.1.3. Increasing awareness about importance of Epilepsy monitoring devices
      • 3.2.1.4. Rising government initiatives
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Limited access to the treatments
  • 3.3. Epilepsy monitoring devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Epilepsy Monitoring Devices Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Epilepsy Monitoring Devices Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Wearable Devices
      • 4.4.1.1. Wearable devices market estimates and forecasts 2018 to 2030, (USD Million)
    • 4.4.2. Conventional Devices
      • 4.4.2.1. Conventional devices market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 5. Epilepsy Monitoring Devices Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Epilepsy Monitoring Devices Market by End Use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospitals & Clinics
      • 5.4.1.1. Hospitals market estimates and forecasts 2018 to 2030, (USD Million)
    • 5.4.2. Ambulatory Surgical Centers
      • 5.4.2.1. Ambulatory surgical centers market estimates and forecasts 2018 to 2030, (USD Million)
    • 5.4.3. Neurology Centers
      • 5.4.3.1. Neurology Centers market estimates and forecasts 2018 to 2030, (USD Million)
    • 5.4.4. Diagnostic Centers
      • 5.4.4.1. Diagnostic Centers market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 6. Epilepsy Monitoring Devices Market: Regional Estimates & Trend Analysis By Product, By End-use

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. North America
    • 6.5.2. U.S.
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. U.S. market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.5.3. Canada
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Canada market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Mexico market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.6. Europe
    • 6.6.1. Europe
    • 6.6.2. UK
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ Reimbursement
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. UK market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.6.3. Germany
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ Reimbursement
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Germany market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.6.4. France
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ Reimbursement
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. France market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.6.5. Italy
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ Reimbursement
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Italy market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.6.6. Spain
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Spain market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.6.7. Denmark
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ Reimbursement
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Denmark market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.6.8. Sweden
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Sweden market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.6.9. Norway
      • 6.6.9.1. Key country dynamics
      • 6.6.9.2. Regulatory framework
      • 6.6.9.3. Competitive scenario
      • 6.6.9.4. Norway market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Asia Pacific
    • 6.7.2. Japan
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ Reimbursement
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Japan market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.7.3. China
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ Reimbursement
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. China market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.7.4. India
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ Reimbursement
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. India market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.7.5. Australia
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ Reimbursement
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Australia market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.7.6. South Korea
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ Reimbursement
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. South Korea market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.7.7. Thailand
      • 6.7.7.1. Key country dynamics
      • 6.7.7.2. Regulatory framework/ Reimbursement
      • 6.7.7.3. Competitive scenario
      • 6.7.7.4. Thailand market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.8. Latin America
    • 6.8.1. Latin America
    • 6.8.2. Brazil
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Brazil market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ Reimbursement
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.9. MEA
    • 6.9.1. MEA
    • 6.9.2. South Africa
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ Reimbursement
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. South Africa market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.9.3. Saudi Arabia
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ Reimbursement
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.9.4. UAE
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ Reimbursement
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. UAE market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.9.5. Kuwait
      • 6.9.5.1. Key country dynamics
      • 6.9.5.2. Regulatory framework
      • 6.9.5.3. Competitive scenario
      • 6.9.5.4. Kuwait market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. NIHON KOHDEN CORPORATION
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Others benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Medtronic
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Others benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. GE Healthcare
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Others benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Koninklijke Philips N.V.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Others benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Compumedics Limited
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Others benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Natsu Medical
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Others benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Cadwell Industries, Inc.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Others benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. BrainScope Company, Inc.
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Others benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Seer Medical
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Others benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Stratus
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Others benchmarking
      • 7.3.13.4. Strategic initiatives
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제